However, similar patterns have been observed for well-known tumor suppressors such as TP53, whose upregulation in leukemic cells is interpreted as a compensatory response to oncogenic stress, rather than a reflection of functional activity (82, 83). The gene discussed is TP53; the disease is neoplasm.